This unanticipated data demonstrating the positive correlation of POLD1 nuclear immunoreactivity with longer overall survival among ccRCC patients, in contrast to several reports regarding other malignancies, may suggest that the potential role of POLD1 can be considered as cancer specific [14,17]. The gene discussed is POLD1; the disease is cancer.